Publications by authors named "A Rubbert-Roth"

Claim this Profile
I
Identification of individuals at high risk of developing rheumatoid arthritis: a balanced random forest model in a cohort of 1544 first-degree relatives.
Romain Aymon, Céline Lamacchia, Benoit Thomas P Gilbert, Maresa Grundhuber, Isabel Gehring, Andrea Rubbert-Roth

RMD Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis.
Daniel Blockmans, Sara K Penn, Arathi R Setty, Wolfgang A Schmidt, Andrea Rubbert-Roth

N Engl J Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD74 autoantibodies in axial spondyloarthritis as biomarkers for activity and severity of disease but not for tumour necrosis factor inhibitor retention: data from the Swiss Clinical Quality Management in rheumatic diseases cohort.
Annik Steimer, Andrea Götschi, Torsten Witte, Almut Scherer, Jonas Brändli, Andrea Rubbert-Roth

Clin Rheumatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study.
Andrea Rubbert-Roth, Koji Kato, Boulos Haraoui, Maureen Rischmueller, Yanxi Liu

Rheumatol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study.
Roy Fleischmann, Sebastian Meerwein, Christina Charles-Schoeman, Bernard Combe, Stephen Hall, Andrea Rubbert-Roth

RMD Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis